|
|
|
|
|||||
|
|
|
The Oncology Institute Inc. (NASDAQ:TOI) is one of the best-performing NASDAQ stocks according to analysts. On June 30, the Oncology Institute announced a partnership with SilverSummit Healthplan. Effective July 1, TOI will serve as the exclusive oncology provider for 80,000+ Medicaid members associated with SilverSummit Healthplan in Nevada.
The collaboration is set to enhance access to advanced cancer care and high-level services for the Medicaid population in the Las Vegas area. SilverSummit Healthplan members now have access to The Oncology Institute’s comprehensive cancer care at 3 distinct locations in Nevada.
The Oncology Institute supports 120+ employed clinicians and 700+ teammates across 70+ clinic locations. The CEO of The Oncology Institute, Daniel Virnich, MD, particularly highlighted TOI’s proven track record of delivering excellent care to Medicaid patients in other regions.
The Oncology Institute Inc. (NASDAQ:TOI) is an oncology company that provides various medical oncology services in the US.
While we acknowledge the potential of TOI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
| Jul-09 | |
| Jun-30 | |
| Jun-03 | |
| May-14 | |
| May-14 | |
| May-13 | |
| May-13 | |
| May-08 | |
| May-07 | |
| May-01 | |
| Apr-30 | |
| Apr-26 | |
| Apr-23 | |
| Apr-22 | |
| Apr-01 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite